Opportunity ID: 323218

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-20-026
Funding Opportunity Title: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.394 — Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 20, 2019
Last Updated Date: Dec 20, 2019
Original Closing Date for Applications: Sep 29, 2020
Current Closing Date for Applications: Sep 29, 2020
Archive Date: Nov 04, 2020
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
City or township governments
Public and State controlled institutions of higher education
Special district governments
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Small businesses
County governments
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U2C Resource-Related Multi-Component Projects and Centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-026.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or after May 25, 2020 PKG00258953 Jan 21, 2020 Sep 29, 2020 View
FORMS-E Use for due dates on or before May 24, 2020 PKG00257237 Jan 21, 2020 May 24, 2020 View

Package 1

Mandatory forms

323218 RR_SF424_2_0-2.0.pdf

323218 PHS398_CoverPageSupplement_5_0-5.0.pdf

323218 RR_OtherProjectInfo_1_4-1.4.pdf

323218 PerformanceSite_2_0-2.0.pdf

323218 RR_KeyPersonExpanded_2_0-2.0.pdf

323218 PHS398_ResearchPlan_4_0-4.0.pdf

323218 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

323218 PHS_Additional_IndirectCosts-1.0.pdf

323218 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

323218 RR_SF424_2_0-2.0.pdf

323218 PHS398_CoverPageSupplement_4_0-4.0.pdf

323218 RR_OtherProjectInfo_1_4-1.4.pdf

323218 PerformanceSite_2_0-2.0.pdf

323218 RR_KeyPersonExpanded_2_0-2.0.pdf

323218 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

323218 PHS_Additional_IndirectCosts-1.0.pdf

323218 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T11:51:35-05:00

Share This Post, Choose Your Platform!

About the Author: